BioLife Solutions , Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced that the Company’s second quarter 2020 financial results will be released after market close on Thursday, August 6th, 2020 , and
July 30, 2020
· 1 min read